Investment
Features
FeesSafety
Academy
More
Pluang+

Investor pessimism rises as bullish sentiment drops to 28.8% in latest AAII survey

Market News
17 Sep 2026
Seeking Alpha
View Source
Bearish
Investor pessimism rises as bullish sentiment drops to 28.8% in latest AAII survey

The latest AAII Sentiment Survey shows a notable shift in individual investor outlook, with bearish sentiment rising by 14 percentage points to 53.3%, while bullish sentiment fell by 9.2 points to 28.8%. Neutral sentiment also declined by 4.8 points to 17.9%. This shift indicates growing pessimism about the short-term stock market prospects among retail investors. The change in sentiment could influence market behavior as investors adjust their expectations and strategies accordingly.

AAII Sentiment Survey pessimism spike offers context for market mood. For readers following US stocks, here is Pluang's market snapshot as of Sep 18, 2026 08:21 WIB: 102 of 150 stocks rose, 47 fell. Moderna rose 8.81% with 54% sell orders, United Microelectronics rose 8.26% with 92% sell orders, Intel rose 7.84% with 69% sell orders.

More News

CodeWall raises $4M to launch AI-driven autonomous attack agents for continuous enterprise security testing.

CodeWall raises $4M to launch AI-driven autonomous attack agents for continuous enterprise security testing.

CodeWall Ltd. has emerged from stealth with $4 million in pre-seed funding to develop AI-powered autonomous attack agents that simulate real-world cyberattacks on enterprises. These agents start from outside the network with no insider access, contin...

Others
Bullish
48 minutes ago
Matchpoint Therapeutics names John O’Malley as Chief Medical Officer to advance autoimmune drug pipeline.

Matchpoint Therapeutics names John O’Malley as Chief Medical Officer to advance autoimmune drug pipeline.

Matchpoint Therapeutics has appointed John O’Malley, M.D., Ph.D., as its Chief Medical Officer. Dr. O’Malley brings extensive experience in immunology and clinical development from his previous roles at CRISPR Therapeutics and Sanofi. His leadership ...

Market News
Bullish
1 hour ago
FDA accepts Orvida Pharma's KM-023 into Rare Disease Evidence Principles process for Olmsted syndrome

FDA accepts Orvida Pharma's KM-023 into Rare Disease Evidence Principles process for Olmsted syndrome

Orvida Pharma announced that the FDA has accepted its lead drug candidate KM-023 (ontivatrep) into the Rare Disease Evidence Principles (RDEP) process for treating Olmsted syndrome, a rare genetic skin disorder. This acceptance allows Orvida to engag...

Market News
Bullish
1 hour ago
DMC Global to release Q3 2026 financial results on October 27 after market close

DMC Global to release Q3 2026 financial results on October 27 after market close

DMC Global Inc. will announce its financial results for the third quarter ending September 30, 2026, on October 27 after the stock market closes. The company will hold a conference call and webcast to discuss the results, providing investors with ins...

Company Fundamentals
Neutral
1 hour ago
Radware launches MCP Server Protection to secure AI integration layers from attacks and abuse.

Radware launches MCP Server Protection to secure AI integration layers from attacks and abuse.

Radware introduced its Model Context Protocol (MCP) Server Protection solution to help organizations secure the integration layer where AI agents connect to enterprise applications and workflows. This new security tool provides visibility into MCP in...

Market News
Bullish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App